Page last updated: 2024-10-19

pyruvaldehyde and Hemangioma, Cavernous, Central Nervous System

pyruvaldehyde has been researched along with Hemangioma, Cavernous, Central Nervous System in 1 studies

Pyruvaldehyde: An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.
methylglyoxal : A 2-oxo aldehyde derived from propanal.

Hemangioma, Cavernous, Central Nervous System: A vascular anomaly composed of a collection of large, thin walled tortuous VEINS that can occur in any part of the central nervous system but lack intervening nervous tissue. Familial occurrence is common and has been associated with a number of genes mapped to 7q, 7p and 3q. Clinical features include SEIZURES; HEADACHE; STROKE; and progressive neurological deficit.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antognelli, C1
Trapani, E1
Delle Monache, S1
Perrelli, A1
Daga, M1
Pizzimenti, S1
Barrera, G1
Cassoni, P1
Angelucci, A1
Trabalzini, L1
Talesa, VN1
Goitre, L1
Retta, SF1

Other Studies

1 other study available for pyruvaldehyde and Hemangioma, Cavernous, Central Nervous System

ArticleYear
KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease.
    Free radical biology & medicine, 2018, 02-01, Volume: 115

    Topics: Animals; Apoptosis; Autophagy; Brain; Cells, Cultured; Central Nervous System Neoplasms; Endothelial

2018